$TSUI

21Shares Sui ETF (TSUI): Termination of a Material Definitive Agreement

21Shares Sui ETF (TSUI) filed an SEC Form 8-K — Termination of a Material Definitive Agreement. false 0002061626 0002061626 2026-06-30 2026-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Original reporting
Published Jul 7, 2026, 8:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 7, 2026, 8:39 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$TSUI
Neutral
medium confidence
Mentioned
$TSUI
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$TSUINeutralMed
01

Why it matters

The contract termination and planned FTSE replacement introduce a scheduled change to the benchmark infrastructure underpinning daily valuation and settlement support, which can affect operational risk and market-making/hedging mechanics.

02

Market read

This is a scheduled benchmark-provider transition for TSUI’s daily NAV valuation, creating a defined future catalyst window (late Aug. 2026).

03

What to watch

Traders should monitor whether the FTSE benchmark’s calculation methodology or publication timing differs, potentially affecting intraday hedging, spreads, and NAV publication expectations around the Aug. 24–31 transition window.

Relevance 6/10Novelty 7/10Timing: Filed July 7, 2026; benchmark termination effective Aug. 31, 2026 with FTSE licensing expected around Aug. 24, 2026.

Background

TSUI uses a third-party “Pricing Benchmark” to value shares daily and calculate NAV; the sponsor terminated the CME CF Sui—USD reference rate license and plans to switch to FTSE index data licensing.

Company-level read

Ticker impact

$TSUINeutralMedium confidence
Context

21Shares Sui ETF (TSUI) disclosed termination of its CME CF Sui pricing benchmark licensing agreement effective Aug. 31, 2026.

Expected impact

Near-term impact likely limited, but the Aug. 31, 2026 benchmark transition creates a future operational/valuation-cadence risk that could affect liquidity/flows around the changeover.

Evidence & confidence

The filing is a primary SEC 8-K contract termination notice; it does not state a change in fund strategy or fees, but it does change the benchmark licensing provider used for valuation and settlement support.

Market effects

Highlights benchmark-provider transition risk for crypto ETPs/ETFs that rely on third-party reference rates for daily valuation.

Primarily impacts US-listed crypto ETP investors and market makers managing NAV/valuation processes.

FTSE’s involvement signals cross-border benchmark administration continuity for digital-asset indices.

Counterpoint

Because the agreement is described as a licensing/benchmark administration change (not a change in the underlying Sui exposure), price impact may be minimal unless the new benchmark materially differs from the prior reference rate.

Key entities

  • 21Shares Sui ETF

    US-listed trust whose sponsor terminated the CME CF Sui pricing benchmark licensing agreement and plans to license FTSE index data.

  • CF Benchmarks Ltd.

    Current administrator of the CME CF Sui—USD reference rate used for TSUI valuation; license terminates effective Aug. 31, 2026.

  • FTSE International Limited

    Planned new benchmark/data provider for TSUI licensing expected around Aug. 24, 2026.

Related articles

$TSUIMed

SUI ETF Debuts on Nasdaq as 21Shares Lists TSUI

21Shares launched a spot Sui ETF on Nasdaq, listed as TSUI, which began trading Tuesday. The launch follows 21Shares’ December 2x leveraged SUI ETF and comes after two other spot Sui ETFs started trading last week. Sui is Mysten Labs’ layer-1 token, with market cap about $3.3 billion.

$WDSMed

Woodside blue ammonia plant stumbles, though CF moves ahead

Woodside Energy is reviewing options, including a sale, for its $2.35B blue ammonia plant in Texas, which is operating below capacity without carbon capture. CF Industries is advancing a $3.7B blue ammonia project in Louisiana. Woodside's CEO cited changing market conditions for the review, while industry-wide uncertainty has led to cancellations of other projects.